Metformin Aurobindo

Metformin Hydrochloride, the active ingredient in Metformin Aurobindo, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients. GNH USA supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Aurobindo is used to improve glycaemic control in disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes. - Polycystic ovary syndrome: may improve insulin resistance and restore ovulatory function.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhoea: frequent loose stools, especially during dose titration. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: when combined with insulin or secretagogues. - Anemia: due to reduced red‑cell production. - Pancreatitis: inflammation of the pancreas.

Metformin should be used with attention to patient‑specific risk factors. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic disease: avoid in patients with significant liver impairment. - Lactic acidosis risk: discontinue before radiographic contrast studies or major surgery. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Drug interactions: review concomitant medications that may affect metformin clearance. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Metformin may interact with several medicines, requiring monitoring or avoidance.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis; hold metformin before and after use. - Cimetidine: can raise metformin plasma concentrations. - Alcohol excess: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium. - Other antidiabetic agents: adjust dose to avoid hypoglycaemia. - Thyroid hormones: may alter glucose metabolism, requiring glucose monitoring.